NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $717,375 | -28.3% | 556,105 | 0.0% | 0.03% | -43.5% |
| Q2 2023 | $1,000,989 | +21.6% | 556,105 | 0.0% | 0.05% | -2.1% |
| Q1 2023 | $823,035 | +5.0% | 556,105 | 0.0% | 0.05% | -13.0% |
| Q4 2022 | $784,108 | -48.7% | 556,105 | 0.0% | 0.05% | -63.8% |
| Q3 2022 | $1,529,000 | -41.5% | 556,105 | 0.0% | 0.15% | -45.6% |
| Q2 2022 | $2,614,000 | +53.7% | 556,105 | +58.9% | 0.27% | +25.1% |
| Q1 2022 | $1,701,000 | +26.0% | 350,000 | +55.6% | 0.22% | +22.3% |
| Q4 2021 | $1,350,000 | – | 225,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners X LLC | 1,676,884 | $18,278,000 | 19.00% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 130,000 | $1,417,000 | 0.82% |
| Lion Point Capital, LP | 300,000 | $3,270,000 | 0.63% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 34,285 | $374,000 | 0.59% |
| Orbimed Advisors | 2,711,013 | $29,550,000 | 0.26% |
| DAFNA Capital Management LLC | 65,000 | $709,000 | 0.21% |
| Virtus ETF Advisers LLC | 23,985 | $261,000 | 0.11% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 31,357 | $342,000 | 0.11% |
| Krensavage Asset Management, LLC | 30,292 | $330,000 | 0.10% |
| Ikarian Capital, LLC | 200,000 | $2,179,000 | 0.10% |